Revisiting the cardiovascular risk of hydroxychloroquine in RA
Nature Reviews Rheumatology, Published online: 30 September 2020; doi:10.1038/s41584-020-00521-xCardiac toxicity can be induced by hydroxychloroquine, especially when used in combination with azithromycin. Interest in hydroxychloroquine and azithromycin as potential therapies for COVID-19 has renewed concerns about the possible cardiovascular risk these drugs present to patients with rheumatoid arthritis.
Source: Nature Reviews Rheumatology - Category: Rheumatology Authors: Yves-Marie Pers Guillaume Padern Source Type: research
More News: Arthritis | Azithromycin | Cardiology | Cardiovascular | COVID-19 | Heart | Hydroxychloroquine | Rheumatoid Arthritis | Rheumatology | Toxicology | Zithromax